Surgical Intervention for Lymphedema

Kristalyn Gallagher; Kathleen Marulanda; Stephanie Gray

doi:10.1016/j.soc.2017.08.001

Surgical Intervention for Lymphedema

Kristalyn Gallagher, Kathleen Marulanda, Stephanie Gray

Department of Surgery

Research output: Contribution to journal › Review article › peer-review

31 Scopus citations

Abstract

Lymphedema is a chronic, progressive disease with no curative treatment. Breast cancer therapy is the most common cause of secondary lymphedema in the developed world. Treatment includes nonsurgical and surgical strategies. Conservative measures are reserved for subclinical lymphedema. Surgical options are divided into physiologic (to restore function) and reductive (to remove diseased tissue). Early stage disease is managed with physiologic procedures. Reductive treatment is reserved for moderate to severe staged disease owing to high morbidity. Surgical options effectively decrease edema and improve quality of life. However, further research is necessary to best establish management of lymphedema.

Original language	English (US)
Pages (from-to)	195-215
Number of pages	21
Journal	Surgical Oncology Clinics of North America
Volume	27
Issue number	1
DOIs	https://doi.org/10.1016/j.soc.2017.08.001
State	Published - Jan 2018

All Science Journal Classification (ASJC) codes

Surgery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.soc.2017.08.001

Cite this

@article{183e3274a0da4b1a830dc99f2b888a77,

title = "Surgical Intervention for Lymphedema",

abstract = "Lymphedema is a chronic, progressive disease with no curative treatment. Breast cancer therapy is the most common cause of secondary lymphedema in the developed world. Treatment includes nonsurgical and surgical strategies. Conservative measures are reserved for subclinical lymphedema. Surgical options are divided into physiologic (to restore function) and reductive (to remove diseased tissue). Early stage disease is managed with physiologic procedures. Reductive treatment is reserved for moderate to severe staged disease owing to high morbidity. Surgical options effectively decrease edema and improve quality of life. However, further research is necessary to best establish management of lymphedema.",

author = "Kristalyn Gallagher and Kathleen Marulanda and Stephanie Gray",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Inc.",

year = "2018",

month = jan,

doi = "10.1016/j.soc.2017.08.001",

language = "English (US)",

volume = "27",

pages = "195--215",

journal = "Surgical Oncology Clinics of North America",

issn = "1055-3207",

publisher = "W.B. Saunders",

number = "1",

}

TY - JOUR

T1 - Surgical Intervention for Lymphedema

AU - Gallagher, Kristalyn

AU - Marulanda, Kathleen

AU - Gray, Stephanie

PY - 2018/1

Y1 - 2018/1

N2 - Lymphedema is a chronic, progressive disease with no curative treatment. Breast cancer therapy is the most common cause of secondary lymphedema in the developed world. Treatment includes nonsurgical and surgical strategies. Conservative measures are reserved for subclinical lymphedema. Surgical options are divided into physiologic (to restore function) and reductive (to remove diseased tissue). Early stage disease is managed with physiologic procedures. Reductive treatment is reserved for moderate to severe staged disease owing to high morbidity. Surgical options effectively decrease edema and improve quality of life. However, further research is necessary to best establish management of lymphedema.

AB - Lymphedema is a chronic, progressive disease with no curative treatment. Breast cancer therapy is the most common cause of secondary lymphedema in the developed world. Treatment includes nonsurgical and surgical strategies. Conservative measures are reserved for subclinical lymphedema. Surgical options are divided into physiologic (to restore function) and reductive (to remove diseased tissue). Early stage disease is managed with physiologic procedures. Reductive treatment is reserved for moderate to severe staged disease owing to high morbidity. Surgical options effectively decrease edema and improve quality of life. However, further research is necessary to best establish management of lymphedema.

UR - http://www.scopus.com/inward/record.url?scp=85034258872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034258872&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2017.08.001

DO - 10.1016/j.soc.2017.08.001

M3 - Review article

C2 - 29132561

AN - SCOPUS:85034258872

SN - 1055-3207

VL - 27

SP - 195

EP - 215

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

IS - 1

ER -

Surgical Intervention for Lymphedema

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this